Crossmark

Elevated serum thyroid stimulating immunoglobulin linked to failure of first-line intravenous methylprednisolone monotherapy in moderate-to-severe thyroid eye disease

Crossref DOI link: https://doi.org/10.1038/s41433-023-02748-w

Published Online: 2023-10-11

Published Print: 2024-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zloto, Ofira https://orcid.org/0000-0002-3548-424X
Rosset, Arza

Priel, Ayelet

Landau-Prat, Daphna https://orcid.org/0000-0002-0910-3829
Cukierman-Yaffe, Tali

Shavit, Ronen

Agmon-Levin, Nancy

Ben Simon, Guy J. https://orcid.org/0000-0002-3967-2694
Sagiv, Oded https://orcid.org/0000-0003-0563-278X
License Information

Text and Data Mining valid from 2023-10-11

Version of Record valid from 2023-10-11
More Information

Article History

Received: 14 January 2023

Revised: 21 April 2023

Accepted: 12 September 2023

First Online: 11 October 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below